Clinical trials help provide patients with new therapies that may work better for them than what is currently available. The ELAINE-3 clinical trial is investigating a targeted endocrine therapy, lasofoxifene, in the treatment of ER+/HER2- metastatic breast cancer. Continue reading to learn more about the study, intervention, and if it may be right for you.
You may qualify to participate in the ELAINE-3 study if you: